Clinical trialNCT03093116RecruitingPhase 1, PHASE2Interventional

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

SponsorTurning Point Therapeutics, Inc.Enrollment500Locally Advanced Solid TumorsMetastatic Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

165 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
Recruiting
Local Institution - 6103
Adelaide, South Australia, Australia
Completed
Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Recruiting
Local Institution - 3301
East Melbourne, Australia
Completed

Belgium

Local Institution - 4802
Antwerp, Belgium
Completed
Local Institution - 4801
Leuven, Belgium
Completed

Canada

Local Institution - 2202
Edmonton, Alberta, Canada
Completed
Local Institution - 2205
Vancouver, British Columbia, Canada
Withdrawn
Local Institution - 2201
Toronto, Ontario, Canada
Completed
Local Institution - 6503
Toronto, Ontario, Canada
Active, not recruiting
Local Institution - 2203
Ontario, Canada
Completed
Local Institution - 2204
Ottawa, Canada
Completed

China

Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting
Local Institution - 6702
Beijing, Beijing Municipality, China
Completed
Daping Hospital, the Third Affiliated Hospital of Third Military Medical University /cancer Center
Daping, Chongqing Municipality, China
Recruiting
Local Institution - 6719
Fuzhou, Fujian, China
Completed
the First Affiliated Hospital of Xiamen University-Oncology
Xiamen, Fujian, China
Recruiting
Guangdong Provincial People'S Hospital
Guangzhou, Guangdong, China
Recruiting
Local Institution - 6733
Guangzhou, Guangdong, China
Completed
Local Institution - 6505
Shenzhen, Guangdong, China
Active, not recruiting
Local Institution - 6504
Shatin, HONG KONG, China
Active, not recruiting
the Affiliated Tumor Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Recruiting
Local Institution - 6710
Wuhan, Hubei, China
Completed
Hunan Cancer Hospital-Thoracic Oncology Ii
Changsha, Hunan, China
Recruiting
Local Institution - 6705
Changsha, Hunan, China
Completed
Local Institution - 6748
Nanjing, Jiangsu, China
Completed
Xuzhou Central Hospital/oncology Department
Xuzhou, Jiangsu, China
Recruiting
Jilin Cancer Hospital/medical Oncology Department
Changchun, Jilin, China
Recruiting
Jilin Cancer Hospital/medical Oncology Department
Changchun, Jilin, China
Recruiting
the First Hospital of Jilin University-Oncology Department
Changchun, Jilin, China
Recruiting
Liaoning Cancer Hospital
Shenyang, Liaoning, China
Recruiting
Tangdu Hospital
Xi'an, Shan3xi, China
Recruiting
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Recruiting
Sichuan Cancer Hospital/medical Oncology Department
Chengdu, Sichuan, China
Recruiting
the First Hospital Affiliated To Amu - Southwest Hospital
Chongqing, Sichuan, China
Recruiting
Local Institution - 6725
Hangzhou, Zhejiang, China
Completed
Zhejiang Cancer Hospital-Oncology
Hangzhou, Zhejiang, China
Recruiting
the Third Xiangya Hospital of Central South University/department of Respiratory and Critical Care Medicine
Changsha, China
Recruiting
West China Hospital Sichuan University/lung Cancer Center
Chengdu, China
Recruiting
the First Affiliated Hospital - Zhejiang University School of Medicine
Hangzhou, China
Recruiting

125 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Mar 2017
Primary completion: 29 Feb 2028
Completion: 29 Feb 2028
Last update posted: 27 May 2026
Registered enrollment: 500
Registry id: NCT03093116

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.